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NCEN The effects of psychiatric distress, inhibition, and 
impulsivity on decision making in patients with 
substance use disorders: A matched control study
Decision Making In Substance-Dependent Patients Désie van Toor,1 Hendrik G. Roozen,2,3 Brittany E. Evans,4 Linda Rombout,5 
Ben J. M. Van de Wetering,5 and Ad J. J. M. Vingerhoets1
1Clinical Psychology Section, Tilburg University, Tilburg, The Netherlands
2Erasmus Medical Centre, Department of Forensic Psychiatry, Rotterdam, The Netherlands
3Novadic-Kentron, Research & Development, Vught, The Netherlands
4Erasmus Medical Centre, Department of Child and Adolescent Psychiatry, Rotterdam, 
The Netherlands
5Bouman Mental Health (GGZ), Rotterdam, The Netherlands
In the present study, the decision making abilities of patients with substance use disorders were compared to those
of healthy controls and, subsequently, the impact of psychiatric distress, behavioral inhibition, and impulsivity on
Iowa Gambling Task (IGT) performance were evaluated. A total of 31 patients and 31 matched healthy controls
performed the IGT and completed the Symptom Checklist-90-Revised (SCL-90-R) and the Behavioral Inhibition
System/Behavioral Activation System (BIS/BAS). The results confirmed that the patient group had severe impair-
ments on the IGT relative to the controls, which appeared to be virtually unrelated to the employed measures. It is
concluded that self-reported psychiatric symptoms, behavioral inhibition, and impulsivity have no impact on the
IGT performance in this patient sample.
Keywords: Alcohol; Drugs; Addiction; Psychiatric symptoms; Impulsivity; Inhibition; Decision making.
INTRODUCTION
Addiction is increasingly considered a chronic and
relapsing brain disorder (Leshner, 1997; McLellan, 2002;
Volkow, Fowler, & Wang, 2004). It has consistently
been found that the progression of addiction leads to
neurochemical and functional disruption of brain regions
including the ventral tegmental area, nucleus accumbens,
amygdala, and prefrontal cortex (Feltenstein & See,
2008). These regions are considered critical in decision
making (Verdejo-García & Bechara, 2009; Verdejo-García,
Pérez-García, & Bechara, 2006b). A well-known and fre-
quently applied computerized psychological task that
simulates complex real-life decision making is the Iowa
Gambling Task (IGT; Bechara, Damásio, Damásio, &
Anderson, 1994). Initially, it was shown that patients
with lesions in the ventromedial prefrontal cortex per-
form poorly on the IGT. They choose high immediate
monetary gain, which terminates in greater long-term
loss as opposed to choices resulting in lower immediate
gain and less long-term loss.
More recently, evidence is accumulating that individ-
uals with brain lesions and various mental diseases,
including substance use disorders, often perform poorly
on tests of decision making and decision making prob-
lems in real-life settings compared to healthy controls
(Bechara et al., 2001). This concerns psychopaths (Van
Honk, Hermans, Putman, Montagne, & Schutter, 2002),
patients with suicidal tendencies (Jollant et al., 2005;
Jollant et al., 2007), patients with anxiety disorders
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and his valuable comments on the research methodology and an earlier draft of this manuscript. Furthermore, we would like to thank
Marcel van Assen (Tilburg University, The Netherlands) for his critical comments and suggestions regarding the statistical analyses.
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162 VAN TOOR ET AL.
(Miu, Heilman, & Houser, 2008), schizophrenic patients
(Kester, Sevy, Yechiam, Burdick, Cervellione, & Kumra,
2006), patients with bipolar disorder (Jollant et al., 2007),
depressive patients (Must et al., 2006), and patients with
borderline personality disorder (Haaland & Landrø,
2007).
With respect to patients with addictive behaviors,
lower scores on the IGT were found in patients with
amphetamine use disorder (Gonzalez, Bechara, & Martin,
2007; Hanson, Luciana, & Sullwold, 2008), individuals
with alcohol use disorders (Gonzalez et al., 2007;
Goudriaan, Oosterlaan, De Beurs, & Van de Brink,
2005), cocaine and heroin polyusers (Verdejo-García,
Rivas-Pérez, Vilar-López, & Pérez-García, 2007), heroin
addicts with co-occurring psychopathy (Vassileva et al.,
2007b), polysubstance users (Hanson et al., 2008), and
pathological gamblers (Goudriaan et al., 2005).
In contrast, several studies on comorbid patients with
substance use disorders failed to demonstrate statistical
significant differences between patients and controls.
These diagnostic groups were schizophrenic patients
with comorbid cannabis use disorders (Mata et al., 2007;
Sevy et al., 2007) and detoxified polysubstance users
with comorbid antisocial personality disorder (Vassileva,
Gonzalez, Bechara, & Martin, 2007a). Surprisingly,
higher levels of antisociality were associated with better
IGT performance. Two overview studies (Bechara &
Damasio, 2002; Bechara & Martin, 2004) concluded that
not all types of substance use disorders manifest IGT
impairments.
From a neurobiological perspective it has been
suggested that substance use disorders and comorbid
psychiatric disorders share common neurobiological
pathways, and that abnormalities of these pathways
have a negative impact on the course, prognosis, and
treatment outcome of these syndromes (Brady & Sinha,
2005; Drake & Brunette, 1998; Rounsaville, Dolinsky,
Babor, & Meyer, 1987). Consequently, comorbid condi-
tions are expected to be associated with increased vulner-
ability to decision-making deficits (Vassileva et al.,
2007b).
Currently, there is mounting evidence that personality
is a central feature in the development of mental disor-
ders, including substance use disorders (Dawe & Loxton,
2004; Verheul, 2001). It has been demonstrated that
alcohol-dependent patients with co-occurring personality
disorders, especially Cluster B personality disorders,
demonstrate significant impairments in decision making
(Dom, de Wilde, Hulstijn, van den Brink, & Sabbe,
2006). The BIS/BAS (Behavioral Inhibition System/
Behavioral Activation System) questionnaire (Carver &
White, 1994) has been constructed to assess individual
differences in personality dimensions that reflect the sen-
sitivity of two motivational systems: the aversive (BIS)
and appetitive (BAS) systems (Gray, 1987). In general,
the activation of the BIS promotes behavior inhibition
(Avila, 2001; Gray, 1987), while perceiving an increased
appetitive value of objects (overactivation of the BAS)
results in impulsive behavior (Gray, 1987; Iacono,
Malone, & McGue, 2008). Therefore, (dis)inhibition and
impulsivity are considered important clinical dimensions
of patients with substance use disorders. Previous work
has demonstrated that the IGT performance is modu-
lated by disinhibition (Crone, Vendel, & van der Molen,
2003). An impaired IGT performance was also found to
be connected with high BAS Fun Seeking scores (Suhr &
Tsanadis, 2007) and a low score on BAS Reward
Responsiveness in nonclinical samples (Franken &
Muris, 2005), although Suhr and Tsanadis (2007) did not
confirm this relationship. On the contrary, these authors
found a statistical trend for an inverse relationship
between IGT performance and BAS Drive (Suhr &
Tsanadis, 2007). In conclusion, the effects of psychiatric
comorbidity and personality makeup on IGT perform-
ance have been inconclusive in patients with substance
use disorders. Consequently, there has been a recent call
for the concurrent assessment of personality and mood
with respect to the clinical appraisal of the IGT perform-
ance (Buelow & Suhr, 2009).
The first objective of the present study is to compare
the IGT performance of an outpatient sample of individ-
uals with substance use disorders to that of matched
healthy controls. The second aim is to examine whether
people with substance use disorders who present with
comorbid psychiatric conditions have more severe
impairments in decision making than those who do not
have these comorbidities. We take into account self-
reported co-occurring psychiatric symptoms (Symptom
Checklist-90-Revised; SCL-90-R) and personality (BIS/
BAS). It is anticipated that having comorbid conditions
in terms of elevated levels of psychiatric symptoms and
high levels of impulsivity and lack of inhibition will con-
tribute to a more negative performance on the IGT.
METHOD
Participants
A total of 62 respondents participated in this matched-
control study: 31 patients with substance use disorders
and 31 healthy controls. The patients were consecutively
admitted to the outpatient Bouman Mental Health
(GGZ) treatment centre in Spijkenisse, The Netherlands,
between March 2007 and August 2008. They all met the
DSM–IV–TR (Diagnostic and Statistical Manual of Men-
tal Disorders–Fourth Edition, Text Revision; American
Psychiatric Association, 2000) criteria for substance use
disorders. Health professionals conducted the assess-
ment by means of clinical interview and several compu-
terized and non-computerized self-report instruments (see
the section “Measures and Procedures”). In this present
research patients were not initially assessed for co-occur-
ring formal psychiatric DSM–IV–TR diagnoses, whereas
symptoms related to substance abuse may exhibit overlap
with discrete comorbid conditions. Nevertheless, several
past diagnoses were obtained from records that included
medical and psychiatric history, such as major depressive
disorder and attention deficit hyperactivity disorder, but
the manifested symptoms were generally considered mild
during assessment. All included patients were nonintra-




































































DECISION MAKING IN SUBSTANCE-DEPENDENT PATIENTS 163
transmittable infectious diseases—for example, tuber-
culosis, hepatitis, and human immunodeficiency virus
(HIV). The results indicated that the included patient
sample can be considered HIV negative. This is import-
ant, since previous research has shown that the HIV status
impacts the IGT performance (Gonzalez, Wardle, Jaco-
bus, Vassileva, & Martin-Thormeyer, 2010; Hardy,
Hinkin, Levine, Castellon, & Lam, 2006). Characteristics
regarding the types of substance are noted in Table 1. The
“drug of choice” was defined as the primary substance
that was used ≥80% of the time during the year that pre-
ceded treatment admission (Gonzalez et al., 2007; Ver-
dejo-García, Bechara, Recknor, & Pérez-García, 2006a).
The control sample was recruited from the same city
community and was case-matched for age, gender, eth-
nicity, and education. These participants completed the
Alcohol Use Disorder Identification Test (AUDIT),
developed by the World Health Organization (WHO) in
order to determine eligibility of participation. The inclu-
sion criterion was an AUDIT score lower than 8 (Saunders,
Aasland, Babor, de la Fuente, & Grant, 1993). Both groups
completed the Mini Mental State Exam (MMSE; Folstein,
Folstein, & McHugh, 1975) prior to the assessment
to examine their global cognitive functioning. The crite-
rion for inclusion was a score equal to or higher than
25. Both groups participated on a voluntary basis and
gave their written informed consent prior to inclusion.
Table 1 summarizes the characteristics of both samples.
Both groups only differed with respect to employment
status.
Measures and procedures
Iowa Gambling Task (IGT)
A computerized (ABCD) version of the Iowa Gambling
Task (IGT) was employed to simulate real-life decision
making in terms of rewards and losses (Bechara et al.,
1994; Bechara, Damasio, Tranel, & Damasio, 1997).
Participants selected cards from four decks that were
shown on a display. Two decks (A′ and B′) gave immedi-
ate high rewards, though at some unpredictable moment
even higher losses resulting in a disadvantageous outcome.
Two other decks (C′ and D′) gave smaller immediate
rewards though also smaller losses, which resulted in
advantageous final outcomes. All participants were
TABLE 1 
Sociodemographic characteristics
Patients (n = 31) Controls (n = 31) Total (n = 62) t(df)/c2(df)
Age (years) 36.42 (12.21) 36.32 (12.36) 36.37 (12.19) 0.05 (60)
Gender (%) Male 54.8 51.6 53.2 0.00 (1)
Female 45.2 48.4 46.8
Ethnicity (%) European 100.0 100.0 100.0
Marital status (%) Single 51.6 32.3 41.9 5.27 (2)
Married/living together 41.9 67.7 54.8
Divorced 6.5 0 3.2
Housing (%) Single 19.4 16.1 17.7 2.06 (5)
With partner 19.4 25.8 22.6
With partner and children 29.0 35.5 32.3
Single with children 3.2 6.5 4.8
With parents 22.6 12.9 17.7
Other 6.5 3.2 4.8
Education (%) Lower 12.9 6.5 9.7 3.09 (2)
Secondary 67.7 54.8 61.3
Higher 19.4 38.7 29.0
Employment (%) Full-time 53.3 51.6 52.5 11.87 (3)**
Part-time 16.7 38.7 27.9
Unemployed 26.7 0 13.1
Other 3.3 9.7 6.6





GAF scoreb 56.41 (8.30)
Note. Mean scores (standard deviations in parentheses) and percentages are given.
aThe primary addiction corresponds with the “drug of choice” definition applied by Gonzalez et al., 2007, and Verdejo-García et al., 2006a. It
reflects the primary substance that was used ≥ 80% of the time during the year that preceded treatment admission. bGAF = Global Assess-
ment of Functioning of the Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition, Text Revision (DSM–IV–TR; American
Psychiatric Association, 2000).




































































164 VAN TOOR ET AL.
instructed to gain as much money as possible by selecting
one card at a time from the four decks until the com-
puter instructed them to stop. The total number of IGT
trials was set at 100 card selections. The dependent mea-
sures for the IGT performance are the net scores, catego-
rized into five blocks of 20 cards each. A net score is
calculated by subtracting the number of cards selected
from the disadvantageous decks from the number
selected from the advantageous decks: (C′ + D′) – (A′ + B′).
Therefore, net scores higher than zero, resulting from
choosing a higher proportion of cards from advanta-
geous decks, indicate a gain of money, while net scores
lower than zero signify a loss of money and are thus con-
sidered disadvantageous (Bechara et al., 2001). The
methodology applied by Sevy et al. (2007) was con-
ducted in order to obtain supplementary information
regarding the learning curve. Consequently, the sum of
the net scores were calculated and dichotomized (1 if
sum net scores were equal to or higher than zero; 0 if
sum net scores were lower than zero) for both groups
corresponding with Trials 1–60 and Trials 61–100. The
IGT is considered a sensitive and an ecologically valid
measure of decision making (Dunn, Dalgleish, & Law-
rence, 2006). In order to increase participants’ motiva-
tion of adequately completing the IGT, 3 participants of
each condition with the highest IGT money gain were
transferred a monetary prize contingent on their IGT
performance (€10, €20, and €30, respectively).
Symptom Checklist-90-Revised (SCL-90-R)
This 90-item self-report questionnaire was adminis-
tered to measure psychiatric symptoms (Derogatis, 1983;
Dutch version by Arrindell & Ettema, 1986). The
response format is a 5-point Likert scale ranging from
“not at all” to “extremely.” The grand mean is consid-
ered a global index of psychiatric distress in individuals
with comorbid substance use disorders (Zack, Toneatto,
& Streiner, 1998). The Cronbach’s alpha of the SCL-90-R
grand mean is .98 in the current sample.
Behavioral Inhibition System/Behavioral 
Activation System (BIS/BAS)
The Behavioral Inhibition System (BIS) and Behavio-
ral Activation System (BAS) were evaluated with the BIS
and BAS scales (Carver & White, 1994; Dutch version by
Franken & Muris, 2005). It consists of 24 items, scored
on a 4-point scale, ranging from “totally agree” to
“totally disagree.” The BIS system is operationalized by
one scale that measures behavioral avoidance or inhibi-
tion (7 items). The BIS system regulates aversive
motives, in which the goal is to move away from some-
thing unpleasant. The BAS system, in contrast, regulates
appetitive motives, in which the goal is to move toward
something desired. The three subscales are the BAS:
BAS Reward Responsiveness (BASRR; 5 items), BAS
Drive (BASD; 4 items), and BAS Fun Seeking (BASFS;
4 items). The internal consistency and test–retest reliabil-
ity are considered sufficient (Jorm et al., 1998). The
Cronbach’s alphas range in the present study from .63
(BASFS) to .74 (BIS).
Analysis
Continuous variables were compared by means of Stu-
dent’s t test, and chi-square statistics were used to evalu-
ate differences in categorical data. Pearson’s (zero-order)
correlations were calculated to evaluate the associations
between IGT net scores, SCL-90-R grand mean, and
subscales of the BIS/BAS. IGT data were analyzed using
a repeated measures general linear model (GLM),
according to the procedure outlined by Bechara et al.
(2001). The five trial-blocks were defined as within-subject
factors and group (patient or control) as the between-
subjects factor. A statistically significant difference was
found between both groups on employment status
(Table 1), which was subsequently converted into three
dummy variables for each subcategory. These dummy
variables were subsequently introduced into the GLM as
covariates. Planned comparisons were employed to com-
pare the IGT performance of both groups by means of
five separate one-way analyses of variance (ANOVAs),
while controlling for employment status.
To examine the unique contribution of comorbid psy-
chiatric symptoms and behavioral inhibition and activa-
tion systems on the IGT performance, two separate
block design hierarchical regression analyses with IGT
net score (mean score of 100 card selections) as the
dependent variable and either the SCL-90-R grand mean
score or BIS/BAS subscales as independent variable were
performed. Furthermore, multicollinearity of variables
was examined, and additional residual analyses were
performed.
All p-values were two-sided and were considered signi-
ficant at p < .05. Computations were performed with the
Statistical Package for Social Sciences (SPSS Version
15.0, 2004, SPSS Inc., Chicago, Illinois).
RESULTS
IGT performance
With respect to both samples, only 21% of the individuals
succeeded in gaining money (i.e., had a positive net score)
after 100 card selections. Furthermore, a comparison was
made regarding the amount of gained money between
patients and controls. A statistically significant difference,
t(60) = 2.37, p = .021, between patients (−1,132.26 USD,
SD = 1,064.56) and controls (−386.78 USD, SD =
1,393.14) was observed. Table 2 displays detailed
information regarding the unadjusted mean scores of the
five IGT trial-blocks. The dichotomized sum net scores
for Trials 0–60 differed from the controls in terms of
learning, but the difference was not statistically signific-
ant (see Table 2). However, for Trials 61–100 this differ-
ence was statistically significant (p = .042). Moreover, a
statistically significant main effect of time for the five IGT
trial-blocks was demonstrated, F(4, 54) = 8.29, p < .001.
This effect was positively linear, F(1, 57) = 13.81, p < .001,
as well as negatively quadratic, F(1, 57) = 13.59, p = .001.
These findings suggest that both groups progressively
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the later trial-blocks, but that the learning effect attenu-
ated with time. Figure 1 depicts the IGT performance
curves of both groups. Further analysis yielded a robust
significant main effect of group, F(1, 57) = 14.95, p <
.001, indicating that the patients made more selections
from the disadvantageous decks than did the controls. In
addition, the interaction effect (Time × Group) yielded a
statistically significant trend, F(4, 54) = 2.38, p = .06.
This interaction effect was positively linear, F(1, 57) =
6.32, p = .015, indicating that the control group showed
a more increasing learning effect than did the patient
group. In order to examine the differences between the
groups, a one-way ANOVA was performed for each of
the five trial-blocks. At the first trial block, the IGT scores
of the two groups did not differ significantly, F(1, 57) =
0.08, p = .780. For all subsequent trial blocks, the scores
were significantly different: Block 2, F(1, 57) =  8.38, p =
.005; Block 3, F(1, 57) = 11.07, p = .002; Block 4, F(1,
57) = 8.25, p = .006; Block 5, F(1, 57) = 10.30, p = .002.
Effect of personality measures (BIS/BAS)
Table 3 displays the zero-order correlations of the BIS/
BAS personality measures and IGT net score. Patients
and controls differed only significantly on BAS Fun Seek-
ing (see Table 2). The GLM indicated that the main effect
of time remained statistically significant for the five IGT
trial-blocks, F(4, 52) = 2.93, p = .03, when controlling for
BASFS. Furthermore, the introduction of BASFS into
the GLM as a covariate did not affect the main effect of
group, F(1, 55) = 11.95, p < .001. Furthermore, a regres-
sion analysis was conducted to examine the strength of
the relation. The group variable and employment were
entered in the first step as covariates of the regression
equation. In the next step the BASF subscale was added.
The accounted variance (R2) was <1% and was statisti-
cally nonsignificant (β = –.02, t = –0.12, p = .902).
TABLE 2 
Unadjusted group effects on SCL-90-R, BIS/BAS, and IGT performance
Patients (n = 31) Controls (n = 31) Total (n = 62) t(df)/c2(df)
SCL-90-R Total score 171.35 (55.88) 107.90 (23.86) 139.63 (53.28) 5.81 (40.59)***
BIS/BASa BIS 20.29 (3.44) 19.07 (4.32) 19.69 (3.91) 1.23 (59)
BASRR 17.10 (2.34) 16.97 (1.94) 17.03 (2.14) 0.24 (59)
BASD 11.13 (2.93) 10.33 (2.09) 10.74 (2.56) 1.22 (59)
BASFS 11.61 (2.45) 10.17 (2.04) 10.90 (2.35) 2.51 (59)*
IGT Total net score −3.48 (26.33) 21.03 (25.30) 8.77 (28.43) −3.74 (60)***
Total score Deck A′ 18.52 (7.99) 15.26 (6.78) 16.89 (7.53) 1.73 (60)
Total score Deck B′ 33.29 (9.74) 24.23 (9.29) 28.76 (10.49) 3.75 (60)***
Total score Deck C′ 24.16 (9.93) 21.97 (7.87) 23.06 (8.96) 0.96 (60)
Total score Deck D′ 24.10 (9.33) 38.55 (15.70) 31.32 (14.73) −4.41 (48.86)***
Net scores Trials 1–20 −4.71 (5.07) −5.03 (5.00) −4.87 (5.00) 0.25 (60)
Net scores Trials 21–40 −0.84 (8.15) 4.06 (8.03) 1.61 (8.39) −2.39 (60)*
Net scores Trials 41–60 0.00 (7.29) 6.13 (7.85) 3.06 (8.12) −3.19 (60)**
Net scores Trials 61–80 1.55 (8.54) 7.81 (8.66) 4.68 (9.10) −2.86 (60)**
Net scores Trials 81–100 0.52 (8.93) 8.26 (8.53) 4.39 (9.50) −3.49 (60)**
Cat. scores Trials 1–60 (0/1)b 19/12 11/20 30/32 3.17 (1)
Cat. scores Trials 61–100 (0/1) 12/19 4/27 16/46 4.13 (1)*
Note. Mean scores (standard deviations in parentheses) and numbers are given. IGT = Iowa Gambling Task. SCL-90-R = Symptom
Checklist-90-Revised. BIS = Behavioral Inhibition System. BAS = Behavioral Activation System. BASRR = BAS Reward Responsive-
ness. BASD = BAS Drive. BASFS = BAS Fun Seeking. Cat. = categorical.
aN = 30 in the control group of all BIS/BAS subscales. bCategorical scores = 1 if Σ net scores for Trials 1–60 or Trials 61–100 ≥ 0, and
= 0 if Σ net scores for Trials 1–60 or Trials 61–100 < 0.
*p < .05. **p < .01. ***p < .001.
Figure 1. Adjusted means of Iowa Gambling Task (IGT) net
scores and comparisons. SUD = patients with substance use
disorders. HC = healthy controls. Error bars represent the
standard errors of the mean (±SEM). *p < .05. **p < .01. ***p
< .001.



































































































166 VAN TOOR ET AL.
Effect of psychiatric comorbidity measured by 
SCL-90-R
Table 3 shows a significant correlation between SCL-
90-R grand mean scores and IGT net scores (r = –.31,
p = .014) and also a strong association between SCL-90-R
grand mean scores and group (r = .60, p < .001).
Because of this correlation, the GLM analysis was omit-
ted. Similar to the aforementioned regression procedure,
the group variable employment and the SCL-90-R
grand mean score were introduced into the regression
model. Again, the accounted variance of the SCL-90-R
was negligible (<1%) and statistically nonsignificant (β
= –.09, t = –0.60, p = .550).
DISCUSSION
The aim of the present study was to compare the IGT
performance of individuals with substance use disorders
to that of matched healthy controls. In addition, the
unique contribution of self-reported co-occurring
psychiatric symptoms and the personality attributes of
inhibition and impulsivity were taken into account with
respect to the IGT scores.
First, consistent with previous findings, we confirmed
that outpatient individuals with substance use disorders
show poorer performance than healthy controls in
decision making, measured by the IGT. While controlling
for employment, the patient group made statistically
significantly more selections from the disadvantageous
decks than did controls. Both groups showed a learning
curve during the five IGT trial-blocks sessions, although
the control group showed the largest increase regarding
the total IGT net score. Overall, our data confirm previ-
ous findings of studies comparing patients with
substance use disorders to controls (Bechara et al., 2001;
Gonzalez et al., 2007; Goudriaan et al., 2005; Hanson
et al., 2008; Verdejo-García et al., 2007). Nevertheless,
it should be noted that the IGT performance displayed
a large variance among both patients and healthy
controls. Therefore it is concluded that decision mak-
ing is not impaired among all substance-dependent
individuals.
Second, unexpected findings regarding the impact of psy-
chiatric symptoms and BASFS on IGT performance were
obtained. Although common neurobiological pathways
and abnormalities have been proposed to underlie impair-
ments in decision making with regard to addictive behav-
iors and psychiatric comorbidity, the present findings fail to
support such commonality. While behavioral mechanisms
of impulsiveness and response inhibition may play a plausi-
ble role in the loss of behavioral control over substance use,
it did not affect the IGT performance. The defects may be
attributed to different neural structures.
It seems conceivable that the employed self-report instru-
ments did capture symptoms that are present in psychiatric
syndromes, though which are insufficient to meet all of the
diagnostic criteria for specific disorders. However, it has
been suggested that IGT impairments underlie both sub-
stance use disorders and personality disorders in addicted
inpatients with comorbid Cluster B personality disorders
(Dom et al., 2006). Such “subclinical” syndromes may not
reach the threshold of a clinical diagnosis and, conse-
quently, may not reach the threshold of having a negative
impact on IGT performance (e.g., Vassileva et al., 2007a).
Additionally, the methodology of the applied assessment
may play a role in the present findings. By using self-
reports, Franken and Muris (2005) failed to confirm the
relation between behavioral decision making and impulsive
personality traits (including the BIS/BAS measure) in a
nonclinical sample. However, more recently such a rela-
tionship has been substantiated by using a task perform-
ance procedure, reflecting orbitofrontal functioning
(Franken, van Strien, Nijs, & Muris, 2008). These findings
suggest that the type of measurement and assessment tech-
niques should be taken into consideration when exploring
relationships between underlying biological processes.
Our study has some notable limitations. Although the
effects of psychiatric comorbidity and personality on
IGT performance were not significant, the role of these
conditions on the IGT performance cannot be ruled out
completely as the current study examined a typical out-
patient sample of patients with substance use disorders
and healthy controls. The findings cannot be generalized
to other diagnostic groups such as inpatient samples or
dually diagnosed patients.
CONCLUSION
Finally, the present findings contribute to the existing
body of evidence that substance abuse is associated with
impaired decision making. Our findings fail to support
the notion that occurrences of psychiatric distress,
behavioral inhibition, impulsivity have an additional
negative impact on the IGT performance in this patient
group. More research is needed regarding the nature and
severity of comorbid conditions and associated underly-
ing neural structures that may be involved in impaired
decision making in patients with substance use disorders.
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TABLE 3 









(n = 62) 
SCL-90-R Total score .02 −.30 −.31*
BIS/BAS BIS .03 .15 .01
BASRR −.11 .16 −.01
BASD −.05 .29 .00
BASFS −.10 .16 −.13
Note. IGT  =  Iowa Gambling Task. SCL-90-R = Symptom
Checklist-90-Revised BIS = Behavioral Inhibition System. BAS  =
Behavioral Activation System. BASRR = BAS Reward Respon-
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